Beijing Scitop Bio-tech Co., Ltd.

Equities

300858

CNE100004181

Food Processing

End-of-day quote Shenzhen S.E. 18:00:00 2024-05-12 EDT 5-day change 1st Jan Change
16.59 CNY -2.12% Intraday chart for Beijing Scitop Bio-tech Co., Ltd. -3.77% -14.04%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Scitop Bio-Tech Co., Ltd. Proposes Final Dividend for the Year 2023 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Scitop Bio-tech Co., Ltd.(XSEC:300858) added to S&P Global BMI Index CI
Lin Wei signed a Share Transfer Agreement to acquire a 6.39% stake in Beijing Scitop Bio-tech Co., Ltd. from Sun Tiansong for approximately CNY 220 million. CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Beijing Scitop Bio-tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 27-JUL-2023. CI
Scitop Bio-tech Gets Patents for Four Biotechnology Inventions MT
Beijing Scitop Bio-Tech Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2023 CI
Chinese Companies to Boost Research to Better Penetrate Probiotics Sector MT
Beijing Scitop Bio-Tech Co., Ltd. Elects Liu Huiyu, Lu Fei and Fang Fang as Independent Directors CI
Beijing Scitop Bio-Tech Co., Ltd. Approves Cash Dividend for 2022 CI
Beijing Scitop Bio-Tech Co., Ltd. Announces the Profit Distribution Proposal for 2022 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Inner Mongolia Lactic Acid Bacteria Technology Research and Development Co., Ltd. announced that it expects to receive CNY 45.14 million in funding from Beijing Scitop Bio-tech Co., Ltd. CI
Beijing Scitop Bio-tech Co., Ltd. announced that it has received CNY 699.999976 million in funding from a group of investors CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Scitop Bio-Tech Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 29 June 2022 CI
Beijing Scitop Bio-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021 CI
Beijing Scitop Bio-Tech Co., Ltd. Announces Profit Distribution Proposal for 2021 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Beijing Scitop Bio-tech Co., Ltd. announced that it expects to receive CNY 700 million in funding from a group of investors CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Chart Beijing Scitop Bio-tech Co., Ltd.
More charts
Beijing Scitop Bio-tech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of compound food additives, edible probiotic products and animal and plant microecological preparations. The Company's main products include compound food additives, edible probiotic products, animal and plant microecological preparations and others. The Company mainly conducts its businesses within the China market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.59 CNY
Average target price
17.67 CNY
Spread / Average Target
+6.51%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300858 Stock
  4. News Beijing Scitop Bio-tech Co., Ltd.
  5. Scitop Bio-tech Gets Patents for Four Biotechnology Inventions
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW